How Prepared Are Pharmacists to Support Atrial Fibrillation Patients in Adhering to Newly Prescribed Oral Anticoagulants?

International Journal of Clinical Pharmacy - Germany
doi 10.1007/s11096-017-0529-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation

JAMA network open
Medicine
2020English

Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2015English

Adherence and Persistence to Direct Oral Anticoagulants in Atrial Fibrillation: A Population-Based Study

Heart
Cardiovascular MedicineCardiology
2019English

How to Use Dabigatran in Patients With Atrial Fibrillation

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2012English

Oral Anticoagulants and Atrial Fibrillation: A South African Perspective

South African Medical Journal
Medicine
2018English

Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy